Details for New Drug Application (NDA): 217692
✉ Email this page to a colleague
The generic ingredient in LIDOCAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 217692
Tradename: | LIDOCAINE HYDROCHLORIDE |
Applicant: | Mankind Pharma |
Ingredient: | lidocaine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 217692
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 217692
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 217692 | ANDA | Lifestar Pharma LLC | 70756-640 | 70756-640-10 | 10 VIAL in 1 CARTON (70756-640-10) / 2 mL in 1 VIAL |
LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 217692 | ANDA | Lifestar Pharma LLC | 70756-640 | 70756-640-25 | 25 VIAL in 1 CARTON (70756-640-25) / 2 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1% | ||||
Approval Date: | Jun 16, 2023 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2% | ||||
Approval Date: | Jun 16, 2023 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1% | ||||
Approval Date: | Nov 29, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription